GLENMARK
Invest Now

Glenmark Pharmaceuticals Share Price
₹1,520.95 +59.15 (4.05%)
27 Mar, 2025 15:10
Start SIP in
GLENMARK
Performance
- Low
- ₹1,450
- High
- ₹1,528
- 52 Week Low
- ₹936
- 52 Week High
- ₹1,831
- Open Price₹1,457
- Previous Close₹1,462
- Volume1,071,208
Investment Returns
- Over 1 Month + 13.99%
- Over 3 Month -2.66%
- Over 6 Month -10.59%
- Over 1 Year + 56.76%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -244.1
- PEG Ratio
- -3.1
- Market Cap Cr
- 42,919
- P/B Ratio
- 5.1
- Average True Range
- 41.61
- EPS
- 0
- Dividend Yield
- 0.2
- MACD Signal
- 9.79
- RSI
- 55.22
- MFI
- 69.48
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,520.95
+
59.15
(4.05%)

-
- Bearish Moving Average 2
-
- Bullish Moving Average 14
- 20 Day
- ₹1,436.60
- 50 Day
- ₹1,443.30
- 100 Day
- ₹1,471.31
- 200 Day
- ₹1,424.13
Resistance and Support
1469.63
- R3 1,514.32
- R2 1,502.03
- R1 1,481.92
- S1 1,449.52
- S2 1,437.23
- S3 1,417.12
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-14 | Quarterly Results | |
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-24 | Audited Results & Final Dividend | |
2024-02-14 | Quarterly Results |
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,520 As on 27 March, 2025 | 14:56
The Market Cap of Glenmark Pharmaceuticals is ₹42919.4 Cr As on 27 March, 2025 | 14:56
The P/E ratio of Glenmark Pharmaceuticals is -244.1 As on 27 March, 2025 | 14:56
The PB ratio of Glenmark Pharmaceuticals is 5.1 As on 27 March, 2025 | 14:56
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.